Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Botanee is a leading Chinese biotechnology company specializing in dermatology and functional skincare, most notably through its flagship brand Winona. The company focuses on the research, development, and production of products designed for sensitive skin, leveraging active ingredients extracted from unique plants found in the Yunnan province. Beyond consumer cosmetics, Botanee invests heavily in clinical dermatology research and is expanding into medical devices and pharmaceutical treatments for skin conditions like atopic dermatitis. The company operates a vertically integrated model encompassing R&D, manufacturing, and an extensive omni-channel distribution network. Botanee is recognized for its evidence-based approach, often collaborating with hospitals and dermatologists to validate the efficacy of its formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunming Botanee Biotechnology.